Monitoring of drugs after marketing.
D004341:Drug Evaluation / Q000379:methods*; D064420:Drug-Related Side Effects and Adverse Reactions; D005069:Evaluation Studies as Topic / Q000379:methods*; D005194:Family Practice; D011358:Product Surveillance, Postmarketing / Q000379:methods*; D012306:Risk; D013223:Statistics as Topic; D006113:United Kingdom